Nursing Notes
By Nufactor

Infusion Nursing Notes By Nufactor

Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Infusion Nursing Notes Blog Logo

This Infusion Nursing Notes blog is published by Nufactor. Since 1999, Nufactor continues to provide specialty products and care for infusion patients in the chronic illnesses community, while addressing the problems of availability, affordability and safety in patient care. Our Infusion Nursing Notes blog brings you timely topics from SCIG / IVIG infusion side effects as well as specialty injectable and infusible therapies for patients with chronic conditions. We provide informational articles on diseases dependent upon these treatments, guides and other resources to managing the safety and health of patients. Our blog is a dedicated resource to connecting infusion nurses with the information and support they need to better care for the patients they serve.

Read the latest Infusion Nursing Notes Blog Post

Intravenous Immune Globulin & Adverse Drug Reaction (ADRs) Management: PART 1: Boxed Warnings & Serious ADRs

Intravenous immune globulin (IVIG) is safe and effective treatment for a variety of medical conditions. Overall IVIG is well-tolerated in most patients. However, it is not without adverse drug reactions (ADRs), ranging from mild to severe. Thorough clinical assessment prior to start of care, astute monitoring during the infusion, post-infusion follow-up, and knowing potential ADRs and how to manage them are key to good patient experience and quality care. A thorough patient assessment should include the patient's health status and vital signs, hydration status, risk factors and co-morbidities, previous immune globulin regimen, and history of ADRs... [ Read Latest Post ]

Meet the Nufactor Infusion Nursing Notes Team

Our team of experts are here to answer your questions and provide helpful information and advice regarding the use and administration of IG products.